Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Azria

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1989
Disposition of sandostatin, a new synthetic somatostatin analogue, in ratsM Lemaire, M Azria, R Dannecker, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 12, 2007
Salmon calcitonin: a review of current and future therapeutic indicationsC H Chesnut, M Azria, S Silverman, et al.
Biochemical and Biophysical Research Communications|August 31, 1992
N-terminal truncation of salmon calcitonin leads to calcitonin antagonists. Structure activity relationship of N-terminally truncated salmon calcitonin fragments in vitro and in vivoJ H Feyen, F Cardinaux, R Gamse, et al.
Calcified Tissue International|July 1, 1994
Comparison of the acute biological action of injectable salmon calcitonin and an injectable and oral calcitonin analogueJ P Devogelaer, M Azria, M Attinger, et al.
Gastroenterologie Clinique Et Biologique|February 1, 1982
[Pharmacokinetics of dihydroergotamine in patients with chronic liver disease (author's transl)]D Labayle, J Chalas, D Lavène, et al.
Calcified Tissue International|November 1, 1987
The effect of rectal and nasal administration of salmon calcitonin in normal subjectsT Buclin, J P Randin, A F Jacquet, et al.
Calcified Tissue International|June 1, 1992
Endogenous production of specific antibodies does not decrease hypocalcemic response to calcitonin in young rabbitsJ Y Reginster, M Azria, S Gaspar, et al.
Calcified Tissue International|April 1, 1996
The effect of intranasal salmon calcitonin on postmenopausal bone turnover as assessed by biochemical markers: evidence of maximal effect after 8 weeks of continuous treatmentM E Kraenzlin, M J Seibel, U Trechsel, et al.
Neuropeptides|September 1, 1984
The myotropic and plasma-calcium modulating effects of calcitonin gene-related peptide (CGRP)J R Tippins, H R Morris, M Panico, et al.
Journal of Clinical Pharmacology|July 28, 2010
Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trialsM A Karsdal, K Henriksen, A C Bay-Jensen, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1989
Disposition of sandostatin, a new synthetic somatostatin analogue, in ratsM Lemaire, M Azria, R Dannecker, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 12, 2007
Salmon calcitonin: a review of current and future therapeutic indicationsC H Chesnut, M Azria, S Silverman, et al.
Biochemical and Biophysical Research Communications|August 31, 1992
N-terminal truncation of salmon calcitonin leads to calcitonin antagonists. Structure activity relationship of N-terminally truncated salmon calcitonin fragments in vitro and in vivoJ H Feyen, F Cardinaux, R Gamse, et al.
Calcified Tissue International|July 1, 1994
Comparison of the acute biological action of injectable salmon calcitonin and an injectable and oral calcitonin analogueJ P Devogelaer, M Azria, M Attinger, et al.
Gastroenterologie Clinique Et Biologique|February 1, 1982
[Pharmacokinetics of dihydroergotamine in patients with chronic liver disease (author's transl)]D Labayle, J Chalas, D Lavène, et al.
Calcified Tissue International|November 1, 1987
The effect of rectal and nasal administration of salmon calcitonin in normal subjectsT Buclin, J P Randin, A F Jacquet, et al.
Calcified Tissue International|June 1, 1992
Endogenous production of specific antibodies does not decrease hypocalcemic response to calcitonin in young rabbitsJ Y Reginster, M Azria, S Gaspar, et al.
Calcified Tissue International|April 1, 1996
The effect of intranasal salmon calcitonin on postmenopausal bone turnover as assessed by biochemical markers: evidence of maximal effect after 8 weeks of continuous treatmentM E Kraenzlin, M J Seibel, U Trechsel, et al.
Neuropeptides|September 1, 1984
The myotropic and plasma-calcium modulating effects of calcitonin gene-related peptide (CGRP)J R Tippins, H R Morris, M Panico, et al.
Journal of Clinical Pharmacology|July 28, 2010
Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trialsM A Karsdal, K Henriksen, A C Bay-Jensen, et al.
Pageof 3